The potential beneficial role of isoflavones in type 2 diabetes mellitus
- 1 November 2018
- journal article
- review article
- Published by Elsevier in Nutrition Research
- Vol. 59, 1-15
Abstract
No abstract availableKeywords
Funding Information
- Russian Science Foundation
- Russian Foundation for Basic Research (16-15-00039, 17-03-00641)
- Ministry of Education and Science of the Russian Federation (4.9514.2017/8.9)
This publication has 85 references indexed in Scilit:
- Soy intake and risk of type 2 diabetes mellitus in Chinese SingaporeansEuropean Journal of Nutrition, 2011
- Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 DiabetesDiabetes, 2011
- Oxidative stress, insulin signaling, and diabetesFree Radical Biology and Medicine, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in miceProceedings of the National Academy of Sciences, 2010
- Genistein Induces Pancreatic β-Cell Proliferation through Activation of Multiple Signaling Pathways and Prevents Insulin-Deficient Diabetes in MiceEndocrinology, 2010
- Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetesThe American Journal of Clinical Nutrition, 2010
- Long-term exposure to genistein improves insulin secretory function of pancreatic β-cellsEuropean Journal of Pharmacology, 2009
- Is equol the key to the efficacy of soy foods?The American Journal of Clinical Nutrition, 2009
- Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal womenMenopause, 2009